News


In the media

DNX Biopharmaceuticals Announces Collaboration With Lung Cancer Initiative at Johnson & Johnson

By JLABS

Read full story
In the media

Talent for Good: "My Company Let Me Take a Month Off Work to Volunteer"

By Alice Oglethorpe

Read full story
In the media

Pharma Must Use Tax-Reform Windfall To Make More Drugs Or Face Backlash - Part II

By Standish Fleming

Read full story
In the media

J&J Launches First JLABS in Europe

By Disha Padmanabha

Read full story
In the media

J&J Opens First JLABS Site In Europe

By Lucie Ellis

Read full story
In the media

New report highlights New York City’s health tech and life science investment landscape

By Stephanie Baum

Read full story
In the media

J&J extends its JLABS incubator scheme to Europe

By Phil Taylor

Read full story
In the media

Belgium chosen for first J&J ‘JLABS’ incubator in Europe

By Andrew McConaghie

Read full story
In the media

Johnson & Johnson opens first European JLABS incubator

By Nick Paul Taylor

Read full story
Press release

Belgium-Based JLINX Incubator to Transition to Johnson & Johnson Innovation JLABS, Expanding Outreach Across Europe

By JLABS

Read full story
In the media

HealthMakers - Episode 2 | Arjun “JJ” Desai – JLABS

By HighDriveTV

Read full story
In the media

Jeremiah Owyang: Why Companies Need An Innovation Program

By Dan Schawbel

Read full story
In the media

Billy Cohn on the Past, Present and Future of the Total Artificial Heart

By Christine Hall

Read full story
In the media

Oil Crisis: As Prices Plunge, Houston Launches $2 Billion Plan To Become 'Third Coast' For Biotech

By Amy Nordrum

Read full story
In the media

Johnson & Johnson: Why Investors Should Consider This Stock for Long-Term Gains

By insight solutions

Read full story